Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
Sciences and active research themes see: http://www.nottingham.ac.uk/mathematics/index.aspx . To find out more about the People and Culture in the School of Mathematical Sciences please visit our website
-
leaders to address the most pressing challenges of the 21st Century through foundational and applied AI research on a cohort basis. The training and supervision will be delivered by a team of outstanding
-
the link: https://research.nottingham.edu.cn/en/persons/yanjun-guan ;https://research.nottingham.edu.cn/en/persons/sam-liang . About the Project. This project will make several contributions to existing
-
opportunities for collaboration. About You The candidate must have obtained a PhD degree within 3 years and in the areas of Management (Sustainability or ESG); Excellent oral and written communication skills in
-
of society’s most pressing global challenges. PhD projects are available across the School’s three strategic research priority areas: Chemistry for Energy, Environment and Sustainability, Chemistry for
-
to advancing women's careers in science. You can read more about what this means at http://www.athenaswan.org.uk/ and on our website http://www.nottingham.ac.uk/chemistry/about/athena-swan.aspx . Information
-
to cover living costs; Join a multidisciplinary cohort to benefit from peer-to-peer learning and transferable skills development. Learn more about the programme, available projects, and the application
-
for the transition from fossil carbon towards a sustainable net-zero future, as well as growth and sustainability of the UK economy and beyond. https://www.nottingham.ac.uk/news/c-loop-ukri C-Loop is a collaborative
-
, email: Yong.Shi@nottingham.edu.cn . Please note that applications sent directly to this email address will not be accepted. Interviews will take place in Ningbo, China, if feasible – virtual interviews
-
, working in close collaboration with Professor J. David Brook (School of Life Sciences, Nottingham) as part of the wider Myotonic Dystrophy drug discovery team. Myotonic dystrophy is the most common form